Head‐to‐head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

Linked Article: Blauvelt et al. Br J Dermatol 2021; 184:1047–1058. L.P. has received consultancy/speaker’s honoraria from and/or participated in clinical trials sponsored by Abbvie, Almirall, Amgen, Baxalta, Biogen, Boehringer Ingelheim, Celgene, Gebro, Janssen, JS BIOCAD, Leo-Pharma, Lilly, Merck-Serono, MSD, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi and UCB.